Registraion of Disinfectants Based on Relative Microbicidal Activity

Infection Control and Hospital Epidemiology

Volumn 25, Issue 4, 2004, Pages 333-341

  Rutala, William A ^a   Weber, David J ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE; ALCOHOL; AMINOCYCLITOL; AMINOGLYCOSIDE; AMMONIUM DERIVATIVE; ANILIDE; BETA LACTAM; BIOCIDE; BRONOPOL; CHLORAMPHENICOL; CHLORHEXIDINE; CHLORINE; COPPER DERIVATIVE; COTRIMOXAZOLE; DISINFECTANT AGENT; ETHYLENE OXIDE; GLUTARALDEHYDE; HYDROGEN PEROXIDE; IODINE; IODOPHOR; ISONIAZID; MERCURY; PHENOL DERIVATIVE; PROPIOLACTONE; QUINOLONE; SULFONAMIDE; TRICLOSAN; TRIMETHOPRIM; VIRUS VACCINE;

ANTIBIOTIC RESISTANCE; DISINFECTION; EVALUATION; METHODOLOGY; MICROBIAL ACTIVITY; PATHOGENESIS; REGISTRATION; REVIEW; CLASSIFICATION; DRUG SCREENING; GOVERNMENT; UNITED STATES;

DISINFECTANTS; DRUG EVALUATION; DRUG RESISTANCE, BACTERIAL; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 1942451881     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502401     Document Type: Review

References (103)

1. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. CDC guideline for disinfection and sterilization in health-care facilities. Federal Register 2003. In press.
2. Rutala WA. APIC guidelines for infection control practice. Am J Infect Control 1996;24:313-342.
3. Rutala WA, Weber DJ. Surface disinfection: should we do it? J Hosp Infect 2001;48:S64-S68.
4. Rutala WA, Cole EC. Ineffectiveness of hospital disinfectants against bacteria: a collaborative study. Infect Control 1987;8:501-506.
5. Rutala WA, Weber DJ. FDA labeling requirements for disinfection of endoscopes: a counterpoint. Infect Control Hosp Epidemiol 1995;16:231-235.
6. Sanders FT. Environmental Protection Agency's role in the regulation of antimicrobial pesticides in the United States. In: Rutala WA, ed. Disinfection, Sterilization, and Antisepsis in Health Care: Principles and Practices in Healthcare. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 1998:28-40.
7. Maillard J-Y. Bacterial target sites for biocide action. J Appl Microbiol 2002;92(suppl):S16-S27.
8. Russell AD. Principles of antimicrobial activity and resistance. In: Block S, ed. Disinfection, Sterilization, and Preservation, ed. 5. Philadelphia: Lippincott Williams & Wilkins; 2001.
9. Hawkey PM. Mechanisms of resistance of antibiotics. Intensive Care Med 2000;26(suppl):S9-S13.
10. Hogan D, Kolter R. Why are bacteria refractory to antimicrobials? Curr Opin Microbiol 2002;5:472-477.
11. Normark BH, Normark S. Evolution and spread of antibiotic resistance. J Intern Med 2002;252:91-106.
12. Jacoby GA. Extended-spectrum β-lactamases and other enzymes providing resistance to oxymino-β-lactams. Infect Dis Clin North Am 1997;11:875-887.
13. Azucena E, Mobashery S. Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. Drug Resist Updat 2001;4:106-117.
14. Philippon A, Arlet G, Jacoby GA. Plasmid-determined ampC-type β-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
15. Chambers HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J Infect Dis 1999;179(suppl 2):S353-S359.
16. Chambers HF. Methicillin-resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781-791.
17. Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1996;26:73-78.
18. Shortridge VD, Doern GV, Brueggemann AB, Beyer JM, Flamm RK. Prevalence of macrolide resistance mechanisms in isolates from a multicenter antibiotic resistance prevalence study conducted in the United States in 1994-1995. Clin Infect Dis 1999;29:1186-1188.
19. Berger-Bachi B. Genetic basis of methicillin resistance in Staphylococcus aureus. Cell Mol Life Sci 1999;56:764-770.
20. Huovinen P. Increases in rates of resistance to trimethoprim. Clin Infect Dis 1997;24(suppl 1):S63-S66.
21. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clin-damycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996;40:1817-1824.
22. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 2001;12:215-223.
23. Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. J Appl Microbiol 2002;92(suppl):S65-S71.
24. Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis 2001;32:1608-1614.
25. Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997;24(suppl 1):S67-S73.
26. Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 1999;43(suppl):S57-S68.
27. Gerba CP, Rusin P. Relationship between the use of antiseptics and disinfectants and the development of antimicrobial resistance. In: Rutala WA, ed. Proceedings of the Conference on Disinfection, Antisepsis and Sterilization: Practices and Challenges for the New Millennium. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001.
28. Russell AD. Mechanisms of bacterial resistance to biocides. International Biodeterioration & Biodegradation 1995;36:247-265.
29. Russell AD. Mechanisms of bacterial resistance to antibiotics and biocides. Prog Med Chem 1998;35:133-197.
30. Jones RD. Bacterial resistance and topical antimicrobial wash products. Am J Infect Control 1999;27:351-363.
31. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999;12:147-179.
32. Russell AD. Mechanisms of bacterial insusceptibility to biocides. Am J Infect Control 2001;29:259-261.
33. Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol 2002;92(suppl):S55-S64.
34. Bloomfield SF. Significance of biocide usage and antimicrobial resistance in domiciliary environments. J Appl Microbiol 2002;92(suppl): S144-S157.
35. Russell AD. Do biocides select for antibiotic resistance? J Pharm Pharmacol 2000;52:227-233.
36. Russell AD. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 2002; 92(suppl):S121-S135.
37. Weber DJ, Rutala WA. Use of germicides in the home and healthcare setting: is there a relationship between germicide use and antimicrobial resistance? Infect Control Hosp Epidemiol. In press.
38. Russell AD. The role of plasmids in bacterial resistance to antiseptics, disinfectants and preservatives. J Hosp Infect 1985;6:9-19.
39. Russell AD. Plasmids and bacterial resistance to biocides. J Appl Microbiol 1997;82:155-165.
40. Heinzel M. Phenomena of biocide resistance in microorganisms. International Biodeterioration & Biodegradation 1998;41:225-234.
41. Rutala WA, Weber DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 2001;32:1348-1356.
42. Barbee SL, Weber DJ, Sobsey MD, Rutala WA. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization. Gastrointest Endosc 1999;49:605-611.
43. Klein M, DeForest A. The inactivation of viruses by germicides. Chemical Specialists Manufacturers Association Proceedings 1963;49:116-118.
44. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999;43:1379-1382.
45. Gold HS, Moellering RC. Drug therapy: antimicrobial-drug resistance. N Engl J Med 1996;335:1445-1453.
46. Cohen FL, Tartasky D. Microbial resistance to drug therapy: a review. Am J Infect Control 1997;25:51-64.
47. Castiglia M, Smego RA. The global problem of antimicrobial resistance. J Am Pharm Assoc (Wash) 1997;NS37:383-387.
48. Levy SB. The challenge of antibiotic resistance. Sci Am 1998;278:46-53.
49. Levy SB. The future of antibiotics: facing antibiotic resistance. Clin Microbiol Infect 2000;6(suppl 3):101-106.
50. Tenover FC. Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 2001;33(suppl 3):S108-S115.
51. Levy SB. Antibiotic resistance: consequences of inaction. Clin Infect Dis 2001;33(suppl 3):S124-S129.
52. Sefton AM. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs 2002;62:557-566.
53. Collignon PJ. Antibiotic resistance. MJA 2002;177:325-329.
54. Leggiadro RJ. The clinical impact of resistance in the management of pneumococcal disease. Infect Dis Clin North Am 1997;11:867-874.
55. Harwell JI, Brown RB. The drug-resistant Pneumococcus: clinical relevance, therapy, and prevention. Chest 2000;117:530-541.
56. Leggiadro RJ. Penicillin-nonsusceptible Pneumococcus. Int J Antimicrob Agents 2000;14:123-127.
57. File TM. Appropriate use of antimicrobial for drug-resistant pneumonia: focus on the significance of β-lactam-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;34(suppl 1):S17-S26.
58. Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 2002;24:1613-1620.
59. Parsons LM, Driscoll JR, Taber HW, Salfinger M. Drug resistance in tuberculosis. Infect Dis Clin North Am 1997;11:905-927.
60. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998;338: 1641-1649.
61. Espinal MA, Laszlo A, Simonsen L, et al. Global trends to antituberculous drugs. N Engl J Med 2001;344:1294-1303.
62. Loddenkemper R, Sagebiel D, Brendel A. Strategies against multidrug-resistant tuberculosis. Eur Respir J Suppl 2002;36:S66-S77.
63. Dye C, Williams BG, Espinal MA, Raviglione MC. Erasing the world's slow strain: strategies to beat multidrug-resistant tuberculosis. Science 2002;295:2042-2046.
64. Lind I. Antimicrobial resistance in Neisseria gonorrhoeae, Clin Infect Dis 1997;24(suppl 1):S93-S97.
65. Ison CA, Dillon J-A, Tapsall JW. The epidemiology of global resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998;351(suppl 3):8-11.
66. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2002 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report, 2001. Atlanta, GA: U.S. Department of Health and Human Services; 2002.
67. Rowe B, Ward LR, Threlfall EJ. Multidrug resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997;24(suppl 1):S106-S109.
68. Threlfall EJ, Ward LR, Frost JA, Willshaw GA. The emergence and spread of resistance in food-borne bacteria. Int J Food Microbiol 2000;62:1-5.
69. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001;32:263-269.
70. Threlaall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 2002;26:141-148.
71. Nuwaha F. The challenge of chloroquine-resistant malaria in sub-Saharan Africa. Health Policy and Planning 2001;16:1-12.
72. Phillips RS. Current status of malaria and potential for control. Clin Microbiol Rev 2001;14:208-226.
73. Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis 2001;184:770-776.
74. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001;64(suppl1-2):12-17.
75. Nosten F, Brasseur P. Combination therapy for malaria: the way forward? Drugs 2002;62:1315-1329.
76. Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci. Infect Dis Clin North Am 1997;11:813-849.
77. Kelley M, Weber DJ, Dooley KE, Rutala WA. Healthcare-associated methicillin-resistant Staphylococcus aureus. Seminars in Infection Control 2001;1:157-171.
78. Eliopoulos GM. Vancomycin-resistant enterococci. Inject Dis Clin North Am 1997;11:851-865.
79. Murray BE. Drug therapy: vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721.
80. Farr BM. Vancomycin-resistant enterococcal infections: epidemiology and control. Seminars in Infection Control 2001;1:148-156.
81. Pootoolal J, Neu J, Wright GD. Glycopeptide antibiotic resistance. Ann Rev Pharmacol Toxicol 2002;42:381408.
82. Patterson JE. Extended-spectrum beta-lactamase-producing gram-negative bacilli. Seminars in Infection Control 2001;1:184-190.
83. Larson LL, Ramphal R. Extended-spectrum beta-lactamases. Semin Respir Infect 2002;17:189-194.
84. Anderson RL, Carr JH, Bond WW, Favero MS. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol 1997;18:195-199.
85. Dychdala GR. Chlorine and chlorine compounds. In: Block SS, ed. Disinfection, Sterilization, and Preservation. Philadelphia: Lippincott, Williams & Wilkins; 2001:135-157.
86. Stickler DJ. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol 2002;92(suppl):S163-S170.
87. Gupta A, Matsui K, Lo J-F, Silver S. Molecular basis for resistance to silver cations in Salmonella. Nat Med 1999;5:183-188.
88. Cooksey DA. Characterization of a copper resistance plasmid conserved in copper-resistant strains of Pseudomonas syringae pv. tomato. Appl Environ Microbiol 1987;53:454-456.
89. Tennent JM, Lyon BR, Midgley M, et al. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. Journal of General Microbiology 1989;135:1-10.
90. Littlejohn TG, DiBerardino D, Messerotti LJ, Spiers SJ, Skurray RA. Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus. Gene 1990;101:59-66.
91. Littlejohn TG, Paulsen IT, Gillespie MT, et al. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett 1992;95:259-266.
92. Leelaporn A, Paulsen IT, Tennent JM, Littlejohn TG, Skurray RA. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J Med Microbiol 1994;40:214-222.
93. Sattar SA. New methods for efficacy testing of disinfectants and antiseptics. In: Rutala WA, ed. Disinfection, Sterilization, and Antisepsis in Health Care: Principles and Practices in Healthcare. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001:173-186.
94. Association of Official Analytical Chemists. Official Methods of Analysis of AOAC International, Association of Official Analytical Chemists, ed. 17. Arlington, VA: Association of Official Analytical Chemists; 2002.
95. Mulberry GK. Current methods of testing disinfectants. In: Rutala WA. Chemical Germicides in Health Care. Morin Heights, Quebec, Canada: Polyscience Publications; 1995:225-236.
96. Sattar SA. Microbicidal testing of germicides: an update. In: Rutala WA, ed. Sterilization, Disinfection and Antisepsis in Health Care. Champlain, NY:. Polyscience Publications; 1998:227-240.
97. Cole EC, Rutala WA, Samsa GP. Standardization of bacterial numbers on penicylinders used in disinfectant testing: interlaboratory study. Journal of the Association of Official Analytical Chemists 1987;70:635-637.
98. Cole EC, Rutala WA, Carson JL. Evaluation of penicylinders used in disinfectant testing: bacterial attachment and surface texture. Journal of the Association of Official Analytical Chemists 1987;70:903-906.
99. Cole EC, Rutala WA. Bacterial numbers on penicylinders used in disinfectant testing: use of twenty-four hour adjusted broth cultures. Journal of the Association of Official Analytical Chemists 1988;71:9-11.
100. Cole EC, Rutala WA, Alfano EM. Comparison of stainless steel penicylinders used in disinfectant testing. Journal of the Association of Official Analytical Chemists 1988;71:288-289.
101. Alfano EM, Cole EC, Rutala WA. Quantitative evaluation of bacteria washed from stainless steel penicylinders during the AOAC use-dilution method. Journal of the Association of Official Analytical Chemists 1988;71:868-871.
102. Cole EC, Rutala WA, Samsa GP. Disinfectant testing using a modified use-dilution method: collaborative study. Journal of the Association of Official Analytical Chemists 1988;71:1187-1194.
103. Cole EC, Rutala WA, Carson JL, Alfano EM. Pseudomonas pellicle in disinfectant testing: electron microscopy, pellicle removal and effect on test results. Appl Environ Microbiol 1989;55:511-513.